Professor David Ackerley (Victoria University of Wellington) is a leading microbiologist and enzyme engineer specializing in directed evolution of bacterial enzymes for biotechnological applications. As Biotechnology Programme Director since 2006, he lectures in foundational courses like BTEC101 and BTEC201. Academic rank: Professor of Biotechnology Institutional affiliation: Victoria University of Wellington Research focus areas: Microbial Biotechnology, Drug Discovery, Synthetic Biology His research employs Darwinian evolutionary principles to engineer enzymes with enhanced activities, particularly targeting non-ribosomal peptide synthetases and nitroreductases for antibiotic development and cancer therapy. Recent work explores metagenomic domain substitution in pyoverdine biosynthesis and Purpuramine R from marine sponges. Key publications demonstrate innovations in metagenomic library construction , CRISPR screening for regeneration genes, and structural characterization of engineered enzymes. His team has developed NTR 2.0 , a high-efficacy nitroreductase for targeted cell ablation. Current research projects include: Clean solutions from dirty genes: Plastic-degrading enzyme discovery Engineering enzymes for CAR T-cell-chemotherapy synergy Repurposing niclosamide against Gram-negative superbugs Grants from the Health Research Council of New Zealand, Royal Society of New Zealand, and Cancer Society of NZ support his work. Collaborations span biomedical research, synthetic biology, and environmental applications.
Gauthier Gidel is an Associate Professor at the Department of Computer Science and Operations Research (DIRO) within the Faculty of Arts and Science at Université de Montréal, where he also holds the prestigious Canada CIFAR AI Chair position. He is a core faculty member of Mila, Quebec's AI research institute, and maintains active research collaborations with leading institutions. His academic journey includes a PhD in Computer Science under the supervision of Simon Lacoste-Julien, with internships at Sierra, ElementAI, and DeepMind during his doctoral studies. Dr. Gidel's research spans multiple critical areas in machine learning, with particular emphasis on generative modeling , adversarial machine learning , and variational inequalities for machine learning. His work explores the intersection of optimization theory and practical AI systems, focusing on challenges like LLM safety alignment, multi-agent cooperation, and robustness against adversarial attacks. He is particularly known for his contributions to understanding the theoretical foundations of generative adversarial networks through variational inequality frameworks. His recent publications reveal a strong trend toward addressing critical challenges in large language model safety and alignment, with numerous 2024-2025 papers focusing on adversarial robustness, safety evaluation methodologies, and alignment techniques for LLMs. Simultaneously, his foundational work continues in optimization theory, particularly in variational inequalities and performative prediction, demonstrating his dual focus on practical AI safety concerns and theoretical machine learning foundations. Canada CIFAR AI Chair Core member of Mila Organizer of popular NeurIPS workshops on smooth games Co-founder of the ICLR blog post track Dr. Gidel actively supervises an extensive research group with approximately 10 current graduate students and numerous alumni who have secured positions at leading institutions including Inria Lyon, Oxford, and industry research labs. His research is supported by multiple substantial grants from CRSNG, MITACS, and IVADO, including the prestigious CRSNG Discovery Grant program and MITACS Acceleration Québec projects focused on fraud detection in music streaming and conditional generation. His laboratory maintains strong connections with both academic and industry partners, fostering a collaborative environment focused on advancing AI safety and theoretical understanding.
Ueli Grossniklaus is an Ordinary Professor at the University of Zurich within the Faculty of Mathematical and Natural Sciences , affiliated with the Department of Plant and Microbiology . His work focuses on plant developmental biology, particularly epigenetic and genetic mechanisms governing reproduction and adaptation. Key Courses: Epigenetics, Plant Biology Workshop, Group Seminars on Current Research Laboratory Techniques: Advanced methods in plant cell mechanics, transcriptomics, and genome editing Research Interests span plant epigenetics, reproductive biology, and the interplay between environmental stress and genetic regulation. He investigates: Mechanistic control of gametogenesis and fertilization Epigenetic contributions to plant adaptation Evolutionary implications of asexual reproduction Biophysical forces in plant cell growth Publication Trends (2025–2018) reveal expertise in: Arabidopsis and fern model systems Epigenetic regulation (DNA methylation, histone dynamics) Apomixis and hybrid seed failure mechanisms Biomechanics of pollen tubes and carnivorous plants Genome editing tools (CRISPR) and long-read sequencing Scientific Collaborations include interdisciplinary projects on: Microfluidic devices for plant cell analysis Gene drive ecology and ethics 3D imaging of plant reproductive structures Advising and Grants focus on mentoring through research internships in developmental biology, genetics, and systems biology. His lab engages in: Epigenetic response to environmental stress Cell wall mechanics in reproduction Computational modeling of plant growth Laboratory Teams integrate plant biologists, bioengineers, and computational scientists to study: Mechanistic gene regulation Evolutionary developmental biology Microrobotics for cellular force measurement
Gerard D Schellenberg is a Professor of Pathology and Laboratory Medicine at the University of Pennsylvania Perelman School of Medicine, with graduate affiliations in Genomics and Computational Biology and Neuroscience. His research focuses on the genetic architecture of Alzheimer's disease and related neurodegenerative disorders, particularly through large-scale genomic studies and neuropathological correlations. Education: B.S. in Biochemistry (minor: Cell Biology), University of California at Riverside, 1973 Ph.D. in Biochemistry (minor: Cell Biology), University of California at Riverside, 1978 NIH Post Doctoral Fellowship, National Institute of Health, 1980-1982 Senior Research Fellow positions at University of Washington departments (1978-1983) Dr. Schellenberg's research program centers on identifying genetic risk factors for Alzheimer's disease through genome-wide association studies (GWAS), whole-genome sequencing, and multi-omics integration. His work emphasizes population diversity, with significant contributions to understanding genetic risk in African American cohorts and sex-specific effects in neurodegeneration. Key focus areas include tauopathies, TDP-43 pathology, and the role of immune-related genes in disease progression. He has pioneered studies on progranulin mutations and their variable phenotypic expression across neurodegenerative conditions. Recent publications reveal a strong trajectory toward multi-ethnic genetic studies, with emphasis on Alzheimer's disease genetics in underrepresented populations , sex differences in cognitive resilience , and novel risk genes like MGMT and DCDC2. His team integrates neuropathological data with genomic findings to establish causal mechanisms, frequently publishing in high-impact journals like Nature Genetics and Alzheimer's & Dementia . Key Scientific Contributions: Leadership in the Alzheimer's Disease Sequencing Project (ADSP) expanding ethnic diversity in genetics research Development of the Alzheimer's Disease Variant Portal (ADVP) for harmonized genetic data Pioneering work on APOE-ε4 modifying loci in African ancestry populations Identification of sex-specific genetic predictors for memory maintenance Dr. Schellenberg directs genomic research initiatives that bridge basic science with clinical neuropathology. His laboratory maintains extensive collaborations with neuropathology cores for autopsy-confirmed diagnoses and leverages multi-ethnic cohorts to address health disparities in dementia research. Current work focuses on elucidating how genetic variants influence tau and TDP-43 pathology across diverse populations, with implications for precision medicine approaches to neurodegenerative diseases.
Miler T. Lee is an Associate Professor at the University of Pittsburgh , focusing on gene regulation during early embryonic development through high-throughput experimental and computational genomics. He earned his Ph.D. in Genomics and Computational Biology in 2009 from the University of Pennsylvania under Dr. Junhyong Kim, followed by postdoctoral work with Dr. Antonio Giraldez at Yale University. Joining the university in 2016, his research spans maternal-to-zygotic transition (MZT), RNA stability, pluripotency networks, and evolutionary developmental biology, utilizing model organisms like zebrafish, Xenopus, and Hydractinia symbiolongicarpus. Key Research Themes: Maternally inherited RNA dynamics during embryogenesis Mechanisms of RNA degradation and transcriptome remodeling Evolution of pluripotency networks in hybrid species Role of zinc signaling in fertilization barriers Computational tools for RNA regulation and sensing Scientific Awards: Pan-American Society for Evolutionary Developmental Biology Junior Faculty Award (2024) Outstanding New Investigator – International Xenopus Board (2023) Basil O'Connor Scholar – March of Dimes (2017-2019) Recent publications highlight his work on enhancer classification, RNA degradation mechanisms, and cross-species MZT comparisons. His lab develops innovative methods like RESA for regulatory sequence analysis and studies evolutionary divergence in RNA localization patterns. While the articles span computational and experimental approaches, they consistently address RNA's role in cellular identity, developmental timing, and evolutionary adaptation. Applications include understanding pluripotency, designing RNA biosensors, and elucidating fertilization barriers. Prospective Ph.D. students are encouraged to contact him for opportunities in gene regulation, development, evo-devo, and computational genomics.
Luke O'Connor is an Assistant Professor of Biomedical Informatics at Harvard Medical School, affiliated with the Department of Biomedical Informatics. He leads the O'Connor Lab, which focuses on the genetic architecture of common diseases, statistical methods development, and translating genetic associations into biological insight. His work bridges computational and experimental approaches to understand the functional and phenotypic effects of genetic variation. Education: O'Connor earned his Ph.D. in Bioinformatics and Integrative Genomics (BIG) from Harvard Medical School in 2019. He was a Schmidt Fellow/Principal Investigator at the Broad Institute of MIT and Harvard before joining Harvard Medical School. Research Interests: His research emphasizes statistical genetics, functional genomics, and the integration of genetic data with phenotypic outcomes. Key areas include analyzing rare and common genetic variants, developing methods for polygenic risk prediction, and studying the impact of genetic perturbations on cellular and disease mechanisms. Grants: He currently leads an NIH-funded project (R35GM155278) investigating the functional and phenotypic effects of protein-coding genetic variation. This work aims to bridge gaps between genomic data and biological understanding. Labs/Teams: The O’Connor Lab collaborates with institutions like the Broad Institute and engages in interdisciplinary projects to advance precision medicine and genetic discovery.
Per Sigvald Bakke is a Professor at the University of Bergen's Faculty of Medicine, Department of Clinical Science, with extensive expertise in respiratory medicine. His research primarily focuses on Chronic Obstructive Pulmonary Disease (COPD), asthma, and related pulmonary conditions, with significant contributions to understanding disease mechanisms, clinical phenotyping, and epidemiology. Dr. Bakke's research interests span COPD phenotyping, asthma heterogeneity, genomics of respiratory diseases, pulmonary function testing, and clinical epidemiology. His work frequently involves large-scale cohort studies and international collaborations, particularly through the U-BIOPRED consortium. His research has significantly advanced understanding of COPD progression, exacerbation risk factors, and the relationship between respiratory diseases and systemic conditions like metabolic syndrome. His publication record demonstrates consistent contributions to respiratory medicine, with recent work focusing on multi-omics approaches to disease phenotyping, genetic determinants of lung function, and clinical management of COPD. His research often bridges basic science with clinical application, addressing critical questions in respiratory disease management and patient outcomes. Dr. Bakke has been instrumental in numerous international collaborative studies including the ECLIPSE cohort, U-BIOPRED, and various genome-wide association studies examining COPD and asthma. His work has contributed to clinical guidelines and improved understanding of respiratory disease mechanisms across diverse populations.
William Balch, PhD, is a Professor in the Department of Molecular and Cellular Biology at Scripps Research. His research focuses on linking genetic variation in human populations to protein function using machine learning tools like Gaussian Process (GP) modeling. He pioneered concepts in proteostasis and spatial covariance, exploring how genetic and environmental factors influence protein folding and disease. Education: Ph.D. in Microbiology from University of Illinois (1979) Research interests include inherited diseases (e.g., CFTR, AATD, NPC1), aging-related proteostasis collapse, and host-pathogen interactions in SARS-CoV-2. His lab develops computational platforms to model protein design and discover therapeutic interventions. Key projects involve GP-based analysis of genetic diversity, small molecule therapeutics targeting chaperone systems, and understanding viral evolution via spatial covariance. His work bridges genomics and phenomics to address disease mechanisms at atomic resolution. Grants and collaborations focus on protein-folding correction, with applications in precision medicine and climate change mitigation through RuBisCo optimization in plants.
Julian Knight is a Professor of Genomic Medicine at the University of Oxford, with affiliations including the Centre for Human Genetics , Merton College , and leadership roles in the NIHR Oxford Biomedical Research Centre and Central and South NHS Genomic Medicine Service . His work bridges clinical practice and research, focusing on translational genomics. Principal Investigator Deputy Director, Centre for Human Genetics Honorary Consultant Physician Tutor and Fellow, Merton College Director, Medical Sciences Division Graduate School Genomic Medicine Theme Lead, NIHR Oxford BRC Research interests include mechanisms of dysregulated immune responses in sepsis , autoimmune disease , and infection . Key contributions involve RNA signature stratification for sepsis outcomes and HLA allele associations in COVID-19 immunogenicity. Current work explores genetic/epigenetic modulators of innate immunity and causal relationships in multi-omic datasets. Recent publications highlight diverse applications of his group’s work: from pleural infection endotyping (2025) to TLR7 variants in severe COVID-19 (2024), with methodological advancements in single-cell demultiplexing (2024) and pathway analysis (2025). Keywords span genomic medicine , immunology , and multi-omic integration . Knight’s leadership extends to clinical implementation of genomics, education (DPhil/MSc programs), and public engagement. Collaborations span institutions including Imperial College , Wellcome Sanger Institute , and Queen Mary University of London .
Cornelius Barry is an Associate Professor in the Department of Horticulture at Michigan State University, with affiliations to the Plant Breeding, Genetics and Biotechnology program, AgBioResearch, and the Molecular Plant Sciences Graduate Program. He joined MSU in July 2007 with a 75% research and 25% teaching appointment. Education: PhD and BSc from the University of Nottingham and University College of Wales Current roles: Director of NSF REU Site: Plant Genomics @ MSU His research focuses on the evolution of biochemical diversity within the Solanaceae family , particularly specialized metabolites like terpenoids, flavonoids, and alkaloids. He investigates their roles in plant defense, pollinator attraction, and human applications through genomics, metabolite profiling, and synthetic biology. Recent publications show expertise in alkaloid biosynthesis , trichome chemistry , and metabolic pathway engineering . Key collaborations include teams at Boyce Thompson Institute, Texas A&M, and University of Nottingham. He advises graduate students in Genetics , Biochemistry & Molecular Biology , and Molecular Plant Sciences programs.
Professor Sander Nieuwenhuis (Leiden University) specializes in Cognitive Neuroscience of Decision Making through behavioral, EEG, and pharmacological approaches. His work bridges prefrontal cortex function and noradrenergic system mechanisms in human cognition. Studied cognitive psychology (Groningen) and earned PhD (Amsterdam, 2001) International experience: Cambridge University (visiting research), Princeton University (postdoc) Research focuses on noradrenaline's role in attention, decision-making, and cognitive control via: Locus coeruleus-norepinephrine system dynamics Phasic vs. tonic alertness effects Cognitive task performance under neuromodulator deficiency Neuroprotective pathways in Alzheimer's models Recent publications analyze DBH deficiency (Jepma et al., 2011) and attentional blink mechanisms (Nieuwenhuis et al., 2005). His Temporal Attention Lab integrates fMRI, genetics, and computational modeling . Teaching leadership includes: Chair of Research Master Program Committee Coordinator of Scientific Writing courses
Raina Plowright serves as the Rudolf J. and Katharine L. Steffen Professor of Veterinary Medicine at Cornell University's College of Veterinary Medicine, where she leads the Department of Public & Ecosystem Health. She is also a Cornell Atkinson Scholar at the Cornell Atkinson Center for Sustainability. Previously, she was a Professor of Epidemiology at Montana State University (2022-present), Associate Professor (2020-2022), and Assistant Professor (2014-2020) in the same department. Plowright earned her B.V.Sc. Hons I (DVM equivalent) from the University of Sydney in 1997, followed by an M.S. in Epidemiology (2005) and Ph.D. in Ecology (2007) from the University of California, Davis. She completed postdoctoral training as a David H. Smith Fellow in Conservation Research at Pennsylvania State University's Center for Infectious Disease Dynamics (2009-2014). Her research program integrates evolutionary biology, ecology, environmental science, immunology, virology, and social sciences to understand and prevent zoonotic spillover—the critical first step in pandemic emergence. She leads transdisciplinary collaborations focused on WHO-priority pathogens originating in bats, with work spanning from sub-cellular to landscape scales. Her team investigates how land-use change, climate variation, and social vulnerability drive pathogen emergence, identifying practical strategies for prevention. Her Plowright Lab and Bat One Health Research Group conduct field studies, laboratory experiments, and predictive modeling to generate actionable insights for public health strategies. Analysis of her recent publications reveals a consistent focus on understanding the ecological and physiological mechanisms driving viral spillover from bats to other species. Her work increasingly emphasizes practical interventions and policy recommendations for pandemic prevention, moving beyond simply understanding spillover mechanisms to implementing ecological countermeasures. Recent research has particularly examined the role of bat nutrition and metabolism in viral shedding dynamics, the spatial and temporal patterns of viral excretion in reservoir hosts, and the development of comprehensive frameworks for primary pandemic prevention. Elected to the National Academy of Medicine (2023) Elected as Fellow of the American Association for the Advancement of Science (2022) Charles and Nora Wiley Award for Meritorious Research (2022) Rudolph J. and Katharine L. Steffen Professorship (2023) DARPA Young Faculty Award (2016) David H. Smith Fellowship in Conservation Research (2009) Plowright co-chairs the Lancet Commission on Prevention of Viral Spillover and serves on the NSF Advisory Committee for Environmental Research and Education. Her research has received significant funding from organizations including DARPA, NSF, and the Morris Animal Foundation. She leads the Plowright Lab and Bat One Health Research Group, which conduct interdisciplinary research spanning field studies, laboratory experiments, and modeling approaches to understand and prevent zoonotic disease emergence. Her laboratory maintains active collaborations with researchers across multiple institutions and countries, working closely with wildlife managers, public health officials, and communities to develop practical strategies for pandemic prevention. The lab's approach emphasizes the integration of ecological knowledge with public health practice through the One Health framework.
Elena Barbieri is a Research Assistant Professor in the Department of Physical Medicine and Rehabilitation at Northwestern University's Feinberg School of Medicine, with dual affiliation at the Mesulam Center for Cognitive Neurology and Alzheimer's Disease. Her interdisciplinary work bridges cognitive neuroscience, clinical neuropsychology, and rehabilitation medicine. Her educational trajectory includes: BS in Cognitive Science from University of Milano-Bicocca (2005) MS in Cognitive Neuroscience from University of Milano-Bicocca (2007) PhD in Cognitive Neuroscience from University of Milano-Bicocca (2012) Postgraduate Training Fellow in Clinical Neuropsychology at Northwestern University (2014) Postdoctoral Fellow in Communication Sciences and Disorders at Northwestern University (2017) Dr. Barbieri's research centers on language-brain relationships with primary focus on aphasia mechanisms and rehabilitation. She investigates both stroke-induced aphasia and Primary Progressive Aphasia (PPA), employing multimodal neuroimaging (structural/functional MRI, PET), electrophysiology (ERP), and noninvasive brain stimulation. Her work examines neural reorganization during recovery, cross-linguistic language processing patterns, and development of culturally adapted assessment tools like the Northwestern Assessment of Verbs and Sentences (NAVS) across Italian, Persian, and German populations. Current projects address TDP-43 pathology progression, virtual reality interventions, and neural mechanisms of syntactic processing in neurodegenerative conditions. Analysis of her 2021-2025 publications reveals strong emphasis on PPA neurobiology, cross-linguistic aphasia rehabilitation, and neural plasticity. Key trends include development of international consensus outcome measures (COS-PPA), investigation of disease-specific progression patterns (TDP-43 pathology), and innovative virtual interventions for dementia-related communication disorders. Her work consistently integrates clinical assessment with advanced neuroimaging to map language network reorganization. Her research excellence is recognized through: Karen Toffler Scholarship for neurodegenerative disease research (2023) Cognitive Neuroscience Society Postdoctoral Fellow Award (2018) Society for Neurobiology of Language Travel Award (2016) Dr. Barbieri serves as Associate Editor for Frontiers in Language Science and maintains active roles in ISTAART and the Academy of Aphasia. Her Mesulam Center affiliation enables collaborative research on cognitive-linguistic deficits in Alzheimer's disease and frontotemporal dementia, with particular focus on developing targeted language interventions for progressive neurodegenerative conditions.
Daniela Strenkert is an Assistant Professor at Michigan State University, affiliated with the MSU-DOE Plant Research Laboratory, Plant Biology Department, Molecular Plant Sciences Program, BioMolecular Science Gateway, and Cell & Molecular Biology Program. Her research focuses on systems biology approaches to understand gene regulation in photosynthetic organisms. Ph.D., University of Kaiserslautern, Germany Her lab investigates photosynthetic performance through multi-omics analysis of chromatin structure, transcriptomes, proteomes, and metabolomes in Chlamydomonas reinhardtii . Key areas include environmental acclimation, histone modification mapping (GreENCODE project), and regulatory RNA characterization. Recent publications emphasize computational modeling of photosynthetic protein interactions, metal homeostasis under stress, and chloroplast protein import mechanisms. Articles span 2025-2010, with 15 most recent from 2025-2022. Her work integrates genome-wide datasets to decode algal regulatory programs under climate change-relevant stressors. She teaches BS 161: Cells and Molecules and maintains a lab at 106 Plant Biology Lab. Contact: strenke2@msu.edu .
Pavel P. Kuksa is a Research Assistant Professor in the Department of Pathology and Laboratory Medicine, specializing in bioinformatics, computer science, and functional genomics. His work focuses on high-throughput sequencing analysis, chromatin interaction data, and developing scalable software platforms for genomics research.
